From cohort entry to 1 year later, n = 1200 | |||||
Year 1 | |||||
Cohort entry | SLEDAI Group | Low | Moderate | Moderately High | Very High |
Low | 70.9 | 15.6 | 9.0 | 4.5 | |
Moderate | 36.3 | 32.3 | 20.2 | 11.3 | |
Moderately high | 30.7 | 24.1 | 32.9 | 12.2 | |
Very high | 19.4 | 15.3 | 29.5 | 35.9 | |
From Year 1 to Year 2 of followup, n = 425 | |||||
Year 2 | |||||
Year 1 | SLEDAI Group | Low | Moderate | Moderately High | Very High |
Low | 67.3 | 14.1 | 12.7 | 5.9 | |
Moderate | 53.9 | 23.0 | 13.0 | 10.0 | |
Moderately high | 35.1 | 17.7 | 35.1 | 12.1 | |
Very high | 22.7 | 22.7 | 30.6 | 24.1 | |
From Year 2 to Year 3 of followup, n = 220 | |||||
Year 3 | |||||
Year 2 | SLEDAI Group | Low | Moderate | Moderately High | Very High |
Low | 58.2 | 16.0 | 19.3 | 6.5 | |
Moderate | 38.3 | 36.1 | 14.9 | 10.7 | |
Moderately high | 33.3 | 15.7 | 39.2 | 11.8 | |
Very high | 17.3 | 13.9 | 34.4 | 34.4 | |
From Year 3 to Year 4 of followup, n = 154 | |||||
Year 4 | |||||
Year 3 | SLEDAI Group | Low | Moderate | Moderately High | Very High |
Low | 52.7 | 33.3 | 12.3 | 1.7 | |
Moderate | 45.7 | 17.1 | 31.5 | 5.8 | |
Moderately high | 18.5 | 23.8 | 42.1 | 15.7 | |
Very high | 12.5 | 16.7 | 33.3 | 37.5 | |
From Year 4 to Year 5 of followup, n = 106 | |||||
Year 5 | |||||
Year 4 | SLEDAI Group | Low | Moderate | Moderately High | Very High |
Low | 52.7 | 27.8 | 16.7 | 2.7 | |
Moderate | 36.0 | 44.0 | 11.9 | 8.0 | |
Moderately high | 22.2 | 19.5 | 47.2 | 11.2 | |
Very high | 11.2 | 11.2 | 22.2 | 55.5 |
↵* Decreasing patient followup data available each year. SLEDAI: Systemic Lupus Erythematosus Disease Activity Index.